These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 26477269)

  • 1. Non-alcoholic fatty liver disease and risk of cardiovascular disease.
    Lonardo A; Sookoian S; Pirola CJ; Targher G
    Metabolism; 2016 Aug; 65(8):1136-50. PubMed ID: 26477269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
    Targher G; Marchesini G; Byrne CD
    Diabetes Metab; 2016 Jun; 42(3):142-56. PubMed ID: 27142870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAFLD: a multisystem disease.
    Byrne CD; Targher G
    J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(3):141-148. PubMed ID: 27692633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].
    Kim HS; Cho YK
    Korean J Gastroenterol; 2017 Jun; 69(6):333-340. PubMed ID: 28637101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.
    Cai J; Zhang XJ; Ji YX; Zhang P; She ZG; Li H
    Circ Res; 2020 Feb; 126(5):679-704. PubMed ID: 32105577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.
    Mantovani A; Ballestri S; Lonardo A; Targher G
    Dig Dis Sci; 2016 May; 61(5):1246-67. PubMed ID: 26809873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
    Potze W; Siddiqui MS; Sanyal AJ
    Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.
    Stahl EP; Dhindsa DS; Lee SK; Sandesara PB; Chalasani NP; Sperling LS
    J Am Coll Cardiol; 2019 Mar; 73(8):948-963. PubMed ID: 30819364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.
    Ballestri S; Lonardo A; Bonapace S; Byrne CD; Loria P; Targher G
    World J Gastroenterol; 2014 Feb; 20(7):1724-45. PubMed ID: 24587651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Adams LA; Anstee QM; Tilg H; Targher G
    Gut; 2017 Jun; 66(6):1138-1153. PubMed ID: 28314735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease and Vascular Disease.
    Forlano R; Mullish BH; Nathwani R; Dhar A; Thursz MR; Manousou P
    Curr Vasc Pharmacol; 2021; 19(3):269-279. PubMed ID: 32188385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric non-alcoholic fatty liver disease: an overview.
    AlKhater SA
    Obes Rev; 2015 May; 16(5):393-405. PubMed ID: 25753407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
    Villela-Nogueira CA; Leite NC; Cardoso CR; Salles GF
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.
    Tana C; Ballestri S; Ricci F; Di Vincenzo A; Ticinesi A; Gallina S; Giamberardino MA; Cipollone F; Sutton R; Vettor R; Fedorowski A; Meschi T
    Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31455011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels?
    Tanoglu A; Kara M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1126-9. PubMed ID: 26193051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.